BELLICUM PHARMACEUTICALS, INC Annual Return On Equity in % from 2015 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Bellicum Pharmaceuticals, Inc quarterly/annual Return On Equity history and growth rate from 2015 to 2022.
  • Bellicum Pharmaceuticals, Inc Return On Equity for the quarter ending September 30, 2023 was 157 %.
  • Bellicum Pharmaceuticals, Inc annual Return On Equity for 2022 was -244 %, a 193% decline from 2021.
  • Bellicum Pharmaceuticals, Inc annual Return On Equity for 2021 was 261 %, a 800% increase from 2020.
  • Bellicum Pharmaceuticals, Inc annual Return On Equity for 2020 was 29 %.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -244 -505 -193% Jan 1, 2022 Dec 31, 2022
2021 261 +232 +800% Jan 1, 2021 Dec 31, 2021
2020 29 +830 Jan 1, 2020 Dec 31, 2020
2019 -801 -685 -594% Jan 1, 2019 Dec 31, 2019
2018 -115 -34.5 -42.7% Jan 1, 2018 Dec 31, 2018
2017 -80.9 -22.9 -39.5% Jan 1, 2017 Dec 31, 2017
2016 -58 -29.5 -103% Jan 1, 2016 Dec 31, 2016
2015 -28.5 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.